ORAL CAVITY SQUAMOUS CELL CARCINOMA
Clinical trials for ORAL CAVITY SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new combo for Tough-to-Treat head & neck cancers
Disease control CompletedThis early-stage study tested the safety of combining two immunotherapy drugs, IRX-2 and durvalumab, for patients with incurable head and neck cancer. The main goal was to find the highest dose patients could tolerate without severe side effects and to see if the treatment increa…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Immunotherapy vs. standard care: a Head-to-Head cancer trial
Disease control CompletedThis trial tested if adding a newer immunotherapy drug (durvalumab) to radiation therapy works better than the standard combination of radiation with an older drug (cetuximab). It was for patients with advanced head and neck cancer who could not safely take the usual chemotherapy…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Virtual surgery planning tested to improve life after jaw cancer
Symptom relief CompletedThis study compared two methods for planning jaw reconstruction surgery in patients with oral or throat cancer. It tested whether using advanced 3D virtual planning before surgery leads to better quality of life outcomes than traditional planning. The main goal was to see if pati…
Matched conditions: ORAL CAVITY SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: UNICANCER • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC